Efficacy and safety of apatinib combined with transarterial chemoembolization (TACE) in treating patients with recurrent hepatocellular carcinoma

BACKGROUND: Apatinib, a vascular endothelial growth factor receptor 2 (VEGFR-2) inhibitor, has shown promising therapeutic effect for hepatocellular carcinoma (HCC). This prospective clinical study was implemented to evaluate the efficacy and safety of apatinib combined with transarterial chemoembol...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Huiying, Li, Jing, You, Nan, Wu, Ke, Wang, Zheng, Wang, Liang, Zhu, Yinan, Liu, Qinqin, Peng, Xuehui, Zheng, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812192/
https://www.ncbi.nlm.nih.gov/pubmed/33490189
http://dx.doi.org/10.21037/atm-20-7244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812192/
https://www.ncbi.nlm.nih.gov/pubmed/33490189
http://dx.doi.org/10.21037/atm-20-7244

Ejemplares similares